[
  {
    "ts": null,
    "headline": "ResMed Inc. stock falls Wednesday, underperforms market",
    "summary": "ResMed Inc. stock falls Wednesday, underperforms market",
    "url": "https://finnhub.io/api/news?id=50a0464cc532a288f78fc45b345ab5ba7e6cbb730388bac948de18b7635ac0ff",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733331540,
      "headline": "ResMed Inc. stock falls Wednesday, underperforms market",
      "id": 131785426,
      "image": "",
      "related": "RMD",
      "source": "MarketWatch",
      "summary": "ResMed Inc. stock falls Wednesday, underperforms market",
      "url": "https://finnhub.io/api/news?id=50a0464cc532a288f78fc45b345ab5ba7e6cbb730388bac948de18b7635ac0ff"
    }
  },
  {
    "ts": null,
    "headline": "Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?",
    "summary": "Haemonetics inks a new agreement to sell its whole blood assets to GVS. The transaction is expected to be closed in the first quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=aafcdcb7230164e9323eeda41b5bfae3c41cf7b812ad1af2e68c50dad8efe9ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733323740,
      "headline": "Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?",
      "id": 131767527,
      "image": "https://media.zenfs.com/en/zacks.com/2e885266f5b1eab5955e24e380130144",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Haemonetics inks a new agreement to sell its whole blood assets to GVS. The transaction is expected to be closed in the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=aafcdcb7230164e9323eeda41b5bfae3c41cf7b812ad1af2e68c50dad8efe9ea"
    }
  },
  {
    "ts": null,
    "headline": "4 Medical Product Stocks to Buy From a Prospective Industry",
    "summary": "An ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. RMD, HAE, PAHC and AGIO are well-poised to gain from the favorable factors.",
    "url": "https://finnhub.io/api/news?id=0060bef8c9842000af558f47357c7da13c0c7438104e9f43cd8ca8991b237cf1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733323320,
      "headline": "4 Medical Product Stocks to Buy From a Prospective Industry",
      "id": 131767528,
      "image": "https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "An ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. RMD, HAE, PAHC and AGIO are well-poised to gain from the favorable factors.",
      "url": "https://finnhub.io/api/news?id=0060bef8c9842000af558f47357c7da13c0c7438104e9f43cd8ca8991b237cf1"
    }
  }
]